Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EV-077 in Healthy and Type 2 Diabetic Subjects
NCT01551381Phase 2Terminated
- Sponsor
- Evolva
- Start
- Jan 2012
- Primary completion
- May 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing EV-077 with Placebo (2 arms). Primary endpoint: Platelet aggregation at 8 days. Started Jan 2012; status: terminated.
02
Drugs
EV-077
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01551381.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01551381.